A Phase II study of Bosentan (Tracleer), a dual endothelin receptor antagonist as monotherapy in patients with stage IV metastatic melanoma

Research output: Contribution to journalArticle

42 Citations (Scopus)
Original languageEnglish
Article numberPMID 17021960
Pages (from-to)247
Number of pages252
JournalInvestigational New Drugs
Volume25
Publication statusPublished - 2007

Cite this